Faeth Therapeutics, Inc.
FTHNasdaqCIK 1829802HealthcareFiscal year ends Dec 31
Reports and events: 130 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2022-08-0907:46 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-22-215634 |
| 2022-07-1917:30 ET | SC 13D | Ownership report, active investor | 0001193805-22-001110 |
| 2022-06-1416:27 ET | 8-K | 5.07 Shareholder vote results | 0001193125-22-173857 |
| 2022-05-1017:03 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0000950170-22-009054 |
| 2022-05-1007:39 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-22-145700 |
| 2022-04-2816:13 ET | DEF 14A | Proxy statementPeriod 2022-06-10 | 0001193125-22-127574 |
| 2022-04-2008:06 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-22-110334 |
| 2022-03-1507:01 ET | 10-K | Annual reportPeriod 2021-12-31 | 0000950170-22-003646 |
| 2022-03-1008:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-22-071338 |
| 2022-03-0916:23 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-22-070592 |
| 2022-01-1008:32 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-22-005156 |
| 2021-12-0608:32 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-21-348517 |
| 2021-11-1616:03 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-21-331187 |
| 2021-11-1017:02 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001564590-21-056273 |
| 2021-11-0909:23 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-21-323938 |
| 2021-09-0808:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-21-267306 |
| 2021-08-1116:12 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0001564590-21-043434 |
| 2021-08-0408:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-21-235775 |
| 2021-08-0208:15 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-21-232433 |
| 2021-06-2816:10 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-21-201933 |
| 2021-06-1716:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-21-193171 |
| 2021-05-1316:19 ET | 10-Q | Quarterly reportPeriod 2021-03-31 | 0001564590-21-027570 |
| 2021-05-1208:20 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-21-158414 |
| 2021-05-0306:33 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-21-146514 |
| 2021-04-0508:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-21-105643 |
| 2021-03-3006:15 ET | 10-K | Annual reportPeriod 2020-12-31 | 0001564590-21-016297 |
| 2021-03-2508:50 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-21-093499 |
| 2021-02-1107:00 ET | 8-K | 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-21-037280 |
| 2021-02-0106:43 ET | S-1/A | Registration statement, amended | 0001193125-21-023615 |
| 2021-01-1516:02 ET | S-1 | Registration statement | 0001193125-21-010054 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 19:01 ET. Listed shows no prices and gives no investment advice.